First Trust Advisors LP Deciphera Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $949,533 - $1.14 Million	71,501 New	71,501 $1.01 Million
Q2 2022 Aug 12, 2022	SELL	$9.11 - $13.98 $375,259 - $575,864	-41,192 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $181,422 - $293,392	26,408 Added 178.63%	41,192 $382,000
Q4 2021 Feb 08, 2022	BUY	$7.7 - $37.13 $113,836 - $548,929	14,784 New	14,784 $144,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.